Clinical trials
Phase 2 beta-Thalassemia trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 3 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 3 |
| Novartis Pharmaceuticals | 2 |
| Shire | 2 |
| Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 1 |
| Consorzio per Valutazioni Biologiche e Farmacologiche | 1 |
| Ente Ospedaliero Ospedali Galliera | 1 |
| Forma Therapeutics, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| La Jolla Pharmaceutical Company | 1 |
| Rare Partners srl Impresa Sociale | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| beta-Thalassemia | 17 |
| Thalassemia | 5 |
| Anemia, Sickle Cell | 3 |
| Iron Overload | 3 |
| alpha-Thalassemia | 2 |
| Anemia | 1 |
| Anemia, Hemolytic | 1 |
| Bone Diseases, Metabolic | 1 |
| Genetic Diseases, Inborn | 1 |
| Hematologic Diseases | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.